Mingyu Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mingyu Kim has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Seung Ho Kim
Department of Radiology, Haeundae Paik Hospital, Inje University College of Medicine, Busan 48108, Republic of Korea
2 shared publications - Dajung Kim
Department of Radiology, Haeundae Paik Hospital, Inje University College of Medicine, Busan 48108, Republic of Korea
1 shared publication - Geon Lee
Department of Radiology, Haeundae Paik Hospital, Inje University College of Medicine, Busan 48108, Republic of Korea
1 shared publication - Hye Ri Kim
Department of Radiology, Haeundae Paik Hospital, Inje University College of Medicine, Busan 48108, Republic of Korea
1 shared publication - Joo Yeon Kim
Department of Pathology, Haeundae Paik Hospital, Inje University College of Medicine, Busan 48108, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 21 October 2026
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 16 (10) , 537
Advanced MR Technique for the Prediction of a Complete Response Following Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Comparative Study Between DWI b2000 and b1000
Background/Objectives: From the viewpoint of personalized medicine, it is important to properly select patients with a complete response (CR) after neoadjuvant chemoradiotherapy (nCRT) because they are candidates for “watch-and-wait” management in locally advanced rectal cancer (LARC). The aims of this study were to evaluate the added value of diffusion-weighted imaging (DWI) b2000 to high-resolution T2-weighted images (HR-T2WI) and to compare the diagnostic performance of DWI b2000 and b1000 for assessing a CR in patients with LARC after nCRT. Methods: This retrospective study included 55 patients (male: 40, female: 15; mean age: 60.1) who underwent pre- and post-nCRT 3T MRI, including DWIb1000 and DWIb2000. Two blinded radiologists independently assessed the likelihood of a CR using a five-point scale across three image sets: T2-weighted images (T2WI), T2WI + DWIb1000, and T2WI + DWIb2000. T2WI were provided because DWI is not used as a standalone sequence in clinical practice when evaluating the therapeutic response to nCRT. A crossover review of DWIb1000 and DWIb2000 with a four-week interval was used to minimize recall bias. The reference standard of a CR was histopathologic examination or clinical remission in cases of watch-and-wait management. For each reader, diagnostic performance was compared across three image sets using pairwise comparisons of the receiver operating characteristic (ROC) curves. Results: The study population comprised 19 patients with a CR and 36 patients with residual tumor. For both readers, adding DWIb2000 significantly enhanced diagnostic performance compared to T2WI alone (AUC for reader 1: 0.918, 0.806, p = 0.0288; AUC for reader 2: 0.868, 0.768, p = 0.0414, respectively), likewise, DWIb1000 (for reader 1: 0.955, p = 0.0015; for reader 2: 0.863, p = 0.0162). However, no significant difference in diagnostic performance was found between DWIb1000 and DWIb2000 for each reader (for reader 1: p = 0.0931; for reader 2: p = 0.8936). Conclusions: Adding DWIb2000 to T2WI improved diagnostic performance for identifying a CR after nCRT compared to T2WI alone. No statistical difference was detected between DWIb1000 and DWIb2000.
- 21 October 2026
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 16 (10) , 537
Open AccessAdvanced MR Technique for the Prediction of a Complete Response Following Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Comparative Study Between DWI b2000 and b1000
Background/Objectives: From the viewpoint of personalized medicine, it is important to properly select patients with a complete response (CR) after neoadjuvant chemoradiotherapy (nCRT) because they are candidates for “watch-and-wait” management in locally advanced rectal cancer (LARC). The aims of this study were to evaluate the added value of diffusion-weighted imaging (DWI) b2000 to high-resolution T2-weighted images (HR-T2WI) and to compare the diagnostic performance of DWI b2000 and b1000 for assessing a CR in patients with LARC after nCRT. Methods: This retrospective study included 55 patients (male: 40, female: 15; mean age: 60.1) who underwent pre- and post-nCRT 3T MRI, including DWIb1000 and DWIb2000. Two blinded radiologists independently assessed the likelihood of a CR using a five-point scale across three image sets: T2-weighted images (T2WI), T2WI + DWIb1000, and T2WI + DWIb2000. T2WI were provided because DWI is not used as a standalone sequence in clinical practice when evaluating the therapeutic response to nCRT. A crossover review of DWIb1000 and DWIb2000 with a four-week interval was used to minimize recall bias. The reference standard of a CR was histopathologic examination or clinical remission in cases of watch-and-wait management. For each reader, diagnostic performance was compared across three image sets using pairwise comparisons of the receiver operating characteristic (ROC) curves. Results: The study population comprised 19 patients with a CR and 36 patients with residual tumor. For both readers, adding DWIb2000 significantly enhanced diagnostic performance compared to T2WI alone (AUC for reader 1: 0.918, 0.806, p = 0.0288; AUC for reader 2: 0.868, 0.768, p = 0.0414, respectively), likewise, DWIb1000 (for reader 1: 0.955, p = 0.0015; for reader 2: 0.863, p = 0.0162). However, no significant difference in diagnostic performance was found between DWIb1000 and DWIb2000 for each reader (for reader 1: p = 0.0931; for reader 2: p = 0.8936). Conclusions: Adding DWIb2000 to T2WI improved diagnostic performance for identifying a CR after nCRT compared to T2WI alone. No statistical difference was detected between DWIb1000 and DWIb2000.
- Open Access
- 23 June 2026
- Published by MDPI AG in Tomography
- Vol. 12 (7) , 91
Inter-Vendor Variability of Perfusion Parameters Derived from Dynamic Contrast-Enhanced MRI in Patients with Prostate Cancer
Purpose: To investigate the agreement on perfusion parameters derived from two different commercially available solutions for dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in patients with prostate cancer (PCa). Methods: A total of 50 patients (mean age, 71.6; range 56–86) who had undergone radical prostatectomy between December 2021 and September 2022 were included in this retrospective study. All patients had undergone DCE-MRI on a single 3T-MR scanner. Tumor segmentation on MR images was performed by two radiologists in consensus after radiologic-pathologic correlation using topographic maps as a reference standard. Subsequently, four perfusion parameters were calculated by dedicated commercially available solutions from two different vendors. Both solutions adopted a population-based arterial input function and an extended Tofts model as the pharmacokinetic model. The perfusion parameters were as follows; volume transfer constant (Ktrans), rate constant (kep), volume fraction of extravascular extracellular space (ve), and volume fraction of plasma (vp). The differences between paired measurements were compared by Bland–Altman analyses and the reproducibility was evaluated using the intraclass correlation coefficient (ICC). Results: The study population consisted of Gleason score (GS) 6 (n = 12), GS 7 (n = 34), GS 8 (n = 1), and GS 9 (n = 3). Significant differences were found for all parameters (p < 0.0001). Mean differences were as follows: Ktrans, −0.2102 (95% confidence interval; −0.2687 to −0.1518); kep, −0.7632 (−0.9005 to −0.6258); ve, −0.1507 (−0.2422 to −0.05907); vp, −0.02929 (−0.03383 to −0.02476). ICCs for average measures were as follows: Ktrans, 0.2989 (−0.2355 to 0.6021); kep, 0.6883 (0.4507 to 0.8231); ve, −0.1331 (−0.9967 to 0.3570); vp, 0.2653 (−0.3106 to 0.5881). Conclusion: All perfusion parameters were significantly different between the two solutions. Therefore, comparison of perfusion parameters across different solutions is not recommended.
- 23 June 2026
- Published by MDPI AG in Tomography
- Vol. 12 (7) , 91
Open AccessInter-Vendor Variability of Perfusion Parameters Derived from Dynamic Contrast-Enhanced MRI in Patients with Prostate Cancer
Purpose: To investigate the agreement on perfusion parameters derived from two different commercially available solutions for dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in patients with prostate cancer (PCa). Methods: A total of 50 patients (mean age, 71.6; range 56–86) who had undergone radical prostatectomy between December 2021 and September 2022 were included in this retrospective study. All patients had undergone DCE-MRI on a single 3T-MR scanner. Tumor segmentation on MR images was performed by two radiologists in consensus after radiologic-pathologic correlation using topographic maps as a reference standard. Subsequently, four perfusion parameters were calculated by dedicated commercially available solutions from two different vendors. Both solutions adopted a population-based arterial input function and an extended Tofts model as the pharmacokinetic model. The perfusion parameters were as follows; volume transfer constant (Ktrans), rate constant (kep), volume fraction of extravascular extracellular space (ve), and volume fraction of plasma (vp). The differences between paired measurements were compared by Bland–Altman analyses and the reproducibility was evaluated using the intraclass correlation coefficient (ICC). Results: The study population consisted of Gleason score (GS) 6 (n = 12), GS 7 (n = 34), GS 8 (n = 1), and GS 9 (n = 3). Significant differences were found for all parameters (p < 0.0001). Mean differences were as follows: Ktrans, −0.2102 (95% confidence interval; −0.2687 to −0.1518); kep, −0.7632 (−0.9005 to −0.6258); ve, −0.1507 (−0.2422 to −0.05907); vp, −0.02929 (−0.03383 to −0.02476). ICCs for average measures were as follows: Ktrans, 0.2989 (−0.2355 to 0.6021); kep, 0.6883 (0.4507 to 0.8231); ve, −0.1331 (−0.9967 to 0.3570); vp, 0.2653 (−0.3106 to 0.5881). Conclusion: All perfusion parameters were significantly different between the two solutions. Therefore, comparison of perfusion parameters across different solutions is not recommended.